Cytomegalovirus drug resistance

Antiviral Therapy

Volumn 3, Issue 4, 1998, Pages 239-242

  Emery, V C ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR;

CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; GENE MUTATION; GENOTYPE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; VIRUS GENE;

EID: 0032442948     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Erice A, Chou S, Biron KK, Stanat SC, Balfour HH Jr & Jordan MC. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. New England Journal of Medicine 1989; 320:289-293.
2. Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF Jr, Matthews TR, Buhles WC et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. Journal of Infections Diseases 1991; 163:716-719.
3. Sullivan V & Coen DM. Isolation of foscarnet-resistant human cytomegalovirus patterns of resistance and sensitivity to other antiviral drugs. Journal of Infections Diseases 1991; 164:781-784.
4. Knox KK, Dorbyski WR & Carrigan DR. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet 1991; 337:1292-1293.
5. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison CA, Kouzarides T, Martignetti JA et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Current Topics in Microbiology and Immunology 1990; 154:125.
6. Littler E, Stuart AD & Chee MS. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 1992; 358:160-162.
7. Sullivan V, Talarico CL, Stanat SC Davis M, Coen DM, Biron KK et al. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus -infected cells. Nature 1992; 358:162-164.
8. Tatti KM, Smith IL & Schinazi RF. Mutations in human cytomegalovirus (HCMV) DNA polymerase associated with antiviral resistance. International Antiviral News 1998; 6:6-9.
9. Bowen EF, Emery VC, Wilson P, Johnson M, Davey CC, Sabin CA, Farmer D & Griffiths PD. Cytomegalovirus polymerase chain reactioon viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS 1998; 1:605-611.
10. Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR & Spector SA. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and polymerase genes. Journal of Infectious Diseases 1997; 176:69-77.
11. Chou S, Guentzel S, Michels KR, Miner RC & Drew WL. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. Journal of Infections Diseases 1995; 172:239-242.
12. Chou S, Erice A, Jordan MC, Vercellotti GM, Michels KR, Talarico CL, Stanat SC & Biron KK. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. Journal of Infections Diseases 1995; 171:576-583
13. Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, Miner RC & Drew WL. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. Journal of Infections Diseases 1997; 176:786-789.
14. Boivin G, Chou S, Quirk MR, Erice A & Jordan MC. Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. Journal of Infections Diseases 1996; 173:523-528.
15. De Clercq E. Therapeutic potential of HPMPC as an antiviral drug. Reviews in Medical Virology 1993; 3:85-96.
16. Bowen EF, Johnson MA, Griffiths PD & Emery VC. Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance. Journal of Virological Methods 1997; 68:225-234.